|
|
||||||||
Original Research |
1 Department of Radiology, Duke University Medical Center, Box 3155, Durham, NC
27710.
2 Division of Radiation Safety, Duke University Medical Center, Durham,
NC.
3 Radiation Safety Office, University of Arkansas, Fayetteville, AR.
Received June 2, 2006;
accepted after revision December 6, 2006.
Address correspondence to T. T. Yoshizumi
(yoshi003{at}mc.duke.edu).
Abstract
|
|
|---|
MATERIALS AND METHODS. Dosimetry measurements were performed in two
ways, one with TLDs and the other with MOSFETs. Twenty organ locations were
selected in an adult anthropomorphic female phantom. High-sensitivity MOSFET
dosimeters were used. For the reference standard, TLDs were placed in the same
organ locations as the MOSFETs. Both MOSFET and TLD detectors were calibrated
with an X-ray beam equivalent in quality to that of a commercial CT scanner
(half-value layer,
7 mm Al at 120 kVp). Organ dose was determined with a
scan protocol for pulmonary embolus studies on a 4-MDCT scanner.
RESULTS. Measurements for selected organ doses and the percentage difference for TLDs and MOSFETs, respectively, were as follows: thyroid (0.34 cGy, 0.31 cGy, -8%), middle lobe of lung (2.4 cGy, 3.0 cGy, +26%), bone marrow of thoracic spine (2.2 cGy, 2.5 cGy, +11%), stomach (1.0 cGy, 0.93 cGy, -6%), liver (2.5 cGy, 2.6 cGy, +6%), and left breast (3.0 cGy, 2.9 cGy, -1%). Bland-Altman analysis showed that the MOSFET results agreed with the TLD results (bias, 0.042).
CONCLUSION. We found good agreement between the results with the MOSFET and TLD methods. Near-real-time CT organ dose assessment not previously feasible with TLDs was achieved with MOSFETs. MOSFET technology can be used for protocol development in the rapidly changing MDCT scanner environment, in which organ dose data are extremely limited.
Keywords: CT dosimetry metal oxide semiconductor field effect transistor radiation dose radiologic physics thermoluminescent dosimeter
|
|
|---|
The purposes of this study were to apply MOSFET technology to CT organ dose assessment and to validate the MOSFET method in comparison with the TLD method as the standard of reference. To the best of our knowledge, this application has not been previously described.
|
|
|---|
|
Anthropomorphic Phantom
We used a commercially available anthropomorphic phantom for the study
[12]. The specifications of
the phantom were a woman 160 cm tall weighing 55 kg
(Fig. 1). The phantom included
bone, lung, and soft-tissue compositions
[12]. It was subdivided into
38 contiguous sections each 2.5 cm thick and had attachable breasts and
anatomic locations for 20 major organs. Each section contained 5-mm-diameter
through holes, and hole locations were optimized for precise dosimetry of
internal organs. Each hole in the phantom was labeled with a number referenced
to in the manufacturer's user manual
[12] for prevention of
detector placement errors in the organs. Unused holes were filled with
tissue-equivalent plugs. Each plug was easily cut into two pieces to hold the
two TLD chips sandwiched between the two plugs. Each MOSFET detector was
inserted in the desired organ hole, care being taken to protect fragile lead
wires. For further protection, we placed a cushion of electrical tape under
the wires (Fig. 2).
|
|
Calibration of Dosimeters
The half-value layer for a single-detector CT scanner (CT/i, GE Healthcare)
has been reported [13] to be
7.24 ± 0.02 mm Al at 120 kVp. We calibrated both MOSFETs and TLDs using
a conventional radiographic X-ray tube. We matched the beam quality to the
reported value [13] by adding
5-mm aluminum sheets to the tube (half-value layer
7 mm Al at 120 kVp).
For calibration, our MOSFET and TLD dosimeters were placed side by side with
an ion chamber (10x5-6 chamber, Radcal) and exposed simultaneously with a
clinical CT beam equal to 140 kVp. Each exposure was measured with a monitor
(MDH 1015, Radcal). Conversion from exposure (roentgens or millicoulombs per
kilogram) to absorbed dose (rad or centigrays) was computed with the f-factor
(0.94 cGy/R), chamber correction factor, and temperature and pressure
correction factors.
MOSFET Dosimeters
For organ dose measurements, we placed high-sensitivity diagnostic MOSFET
dosimeters (TN-1002RD, Best Medical Canada) in 20 organ locations. Doses were
measured immediately after each scan, which can be considered near real-time
conditions. For calibration, a group of MOSFET detectors were exposed three
times at four exposure levels (50-1,500 mR [12.9-387 x 10-6
C/kg]), and the mean MOSFET readout (millivolts) and SD were computed. The
least-squares fit routine (Prism, version 2.0, 1995, GraphPad Software) was
used to obtain a calibration curve (MOSFET vs ion chamber measurement) by a
fit of four MOSFET measurements to corresponding soft-tissue doses
(centigrays) from an ion chamber. The slope of the linear regression curve
gave a calibration factor for each MOSFET. Individual millivolt to centigray
dose conversion factors (mV/cGy) for all 20 MOSFET detectors were computed
with AutoSense software (Thomson-Nielsen TN-RD-49, Best Medical Canada) and
stored in a laptop computer.
Uncertainty in MOSFET measurements was estimated on the basis of the
measured percentage uncertainties (1 SD - 1
) as a function of MOSFET
value. As shown in Figure 3,
percentage SD increased as the dose to a MOSFET decreased. We selected the
dose at the 25% SD level as the lower limit of detection (1.40 mGy)
[1,
2]. The data were fitted to a
one-phase exponential model as follows: y(%SD) = 98.78 x
exp[-0.01472 x x(mrad)] + 11.08. Goodness of fit was
R2 = 0.9790. MOSFET error bars were estimated with this
equation.
|
Statistical Analysis
Bland-Altman analysis was used to compare agreement between the two
methods, that is, MOSFET versus TLD. All of the organ dose values in
Table 2 were used to produce a
Bland-Altman plot. The plot was a computation of the average of the two values
(TLD and MOSFET for each organ) and the difference between the two
measurements (Prism, version 4.0, 2005).
|
|
|
|---|
|
|
|
|
|---|
There was a factor-of-two difference in the left upper lobe of the lung (1.6 vs 0.88 cGy, -44%) and right breast (3.4 vs 1.8 cGy, 49%). We believe this difference is explained by the CT helical beam's not falling on the same organ location at the same point of the arc because of differences in the X-ray tube start angle between the TLD and MOSFET measurements.
The percentage differences increased for organs located away from the chest region. For example, bone marrow in the pelvis exhibited a 145% difference between TLD and MOSFET (0.013 vs 0.033 cGy). The large percentage difference was due to the difference in the lower limit of detection between TLD and MOSFET. We [3] have reported previously that the lower limit of detection for MOSFETs is approximately 1.40 mGy (140 mrad) at 25% (1 SD) compared with a TLD value of 0.10-0.20 mGy (10-20 mrad). In this example, the MOSFET measurement was 0.033 cGy (33 mrad), well below the lower limit of detection (140 mrad [0.14 cGy]). As a result, MOSFET technology has a limitation in low-dose applications. CT organ doses, however, are usually approximately 0.01-0.1 cGy. Therefore, this MOSFET limitation is not usually a problem for organ dose measurements within the scanned region.
We conclude that good agreement (bias, 0.042; Bland-Altman analysis) was found between MOSFET measurement and the TLD method; that the MOSFET technique allows near-real-time CT organ dose assessment, which was previously unfeasible; and that MOSFET technology is useful for new protocol development in the fast-changing field of MDCT technology.
Acknowledgments
We thank H. Mike Scribner, Radiation Oncology Physics Laboratory, for
technical support with the TLD analyzer. We also thank Carolyn Lowry,
Department of Radiology, for CT scan support.
|
|
|---|
This article has been cited by other articles:
![]() |
S. Kim, G. Toncheva, C. Anderson-Evans, B. K. Huh, L. Gray, and T. Yoshizumi Kerma Area Product Method for Effective Dose Estimation During Lumbar Epidural Steroid Injection Procedures: Phantom Study Am. J. Roentgenol., June 1, 2009; 192(6): 1726 - 1730. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Marin, R. C. Nelson, E. Samei, E. K. Paulson, L. M. Ho, D. T. Boll, D. M. DeLong, T. T. Yoshizumi, and S. T. Schindera Hypervascular Liver Tumors: Low Tube Voltage, High Tube Current Multidetector CT during Late Hepatic Arterial Phase for Detection--Initial Clinical Experience Radiology, June 1, 2009; 251(3): 771 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, T. T. Yoshizumi, G. Toncheva, S. Yoo, and F.-F. Yin COMPARISON OF RADIATION DOSES BETWEEN CONE BEAM CT AND MULTI DETECTOR CT: TLD MEASUREMENTS Radiat Prot Dosimetry, December 13, 2008; (2008) ncn305v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Jaffe, T. T. Yoshizumi, G. I. Toncheva, G. Nguyen, L. M. Hurwitz, and R. C. Nelson Early First-Trimester Fetal Radiation Dose Estimation in 16-MDCT Without and With Automated Tube Current Modulation Am. J. Roentgenol., April 1, 2008; 190(4): 860 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Coursey, D. P. Frush, T. Yoshizumi, G. Toncheva, G. Nguyen, and S. B. Greenberg Pediatric Chest MDCT Using Tube Current Modulation: Effect on Radiation Dose with Breast Shielding Am. J. Roentgenol., January 1, 2008; 190(1): W54 - W61. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Hollingsworth, T. T. Yoshizumi, D. P. Frush, F. P. Chan, G. Toncheva, G. Nguyen, C. R. Lowry, and L. M. Hurwitz Pediatric Cardiac-Gated CT Angiography: Assessment of Radiation Dose Am. J. Roentgenol., July 1, 2007; 189(1): 12 - 18. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |